TCL Archive Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy September 27, 2013
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails May 25, 1979
